Dr. Sen-itiroh Hakomori couldnt leave his lab work alone. He would often log 13-hour days, seven days a week, and even spend some time at his job on Christmas morning, intensely focused on his glycosphingolipid medical and biochemical research.
I realized fairly recently that all of the cells are just like a pet. You have to check up on them and make sure that things are going well because theyre alive, said his daughter Naoko Vaughn. As children, we did not understand why he went to work every single day. I realized that he had to.
Vaughns father, who she said had a heart of gold and would help anybody, died of natural causes at the age of 91 on Nov. 10 at his home on Mercer Island.
Roger Laine, a colleague and friend who was the last professor to visit Hakomori, said that he was truly a pioneering scientist in glycobiology, a field in which he spent seven decades participating in groundbreaking studies.
He worked most of his career showing differences between cancer cells and normal cells that could be targeted for therapy. If you asked him what was his goal in life, he would answer, cure cancer, said Laine, a professor, scientist and researcher at Louisiana State University.
Hakomori is survived by his wife, Mitsuko (they were married for 74 years); Vaughn; sons, Yoichiro and Kenjiro; four grandchildren and two great-grandchildren; two brothers and a sister.
A native of Japan, professor Hakomori made crucial contributions to new cancer-cell studies at the Cancer Research Institute at Tohoku Pharmaceutical University, and continued his vast research in the field when the family immigrated to the United States to the Boston area.
The family moved from Boston to Bellevue in the late 1960s and set up their new home on Mercer Island 46 years ago. Hakomori relocated his family to the Pacific Northwest to become involved with the Fred Hutchinson Cancer Research Center, and served as University of Washington professor of pathobiology and professor of microbiology. He was named a UW professor emeritus of pathobiology and global health in 2006.
Hakomori retired at the age of 88, finishing his career working at the Pacific Northwest Cancer Center in Seattle. During a celebration in Japan three years ago, Hakomori who was a member of the prestigious National Academy of Sciences spoke to the attendees and noted, We are all globally connected with research and science.
His two sons reflected on their fathers vital contribution to their lives.
Dad was passionate about his work and a great mentor to many of his younger colleagues. He has inspired me to try to emulate that passion in the work I do as an architect and professor, said Yoichiro.
Added Kenjiro: Dad taught me by example to work hard on trying to find out and work on resolving research questions it is a lifelong passion.
Vaughn added that her father instilled a high-level work ethic in his children, telling them, Whatever you do, whatever you choose to do, whatever your passion is, you do it 120 percent.
Hakomori made a worldwide impact with his research and was nominated five times for the Nobel Prize in chemistry. He received numerous awards, including the Philip Levine Immunohematology Award, the Karl Meyer Award from the Society of Glycobiology and the Rosalind Kornfield Award for Lifetime Achievement in Glycobiology.
He published 585 articles in peer-reviewed journals, and a pair of his many major scientific achievements were methylation analysis of glycoconjugates with mass spectrometry, and cell adhesion based on carbohydrate-carbohydrate interaction, particularly through GSL clusters at the embryonic stem cell surface.
He was very honored in his work, and he did not do it for money. He was very much just trying to help, which is rare these days, said Vaughn, adding that a host of his students and colleagues from around the world are assembling a memorial for her father to be published in a glycosphingolipid journal.
He was just a wonderful person. I think the most important thing is his colleagues really admired him. He made them successful in their lives, Vaughn added.
When Sarah Spiegel was a graduate student, she was drawn to Hakomoris papers and reviews on the role of glycoconjugates in cancer. Those documents sparked her imagination and inspired her to pursue a career in sphingolipids, she wrote on the Evergreen Washelli Funeral Home & Cemetery memorial page.
He was a champion of advancing careers of young female scientists and his generous spirit influenced my generation and generations to come, said Spiegel, Ph.D., professor and chair in the Department of Biochemistry and Molecular Biology at the Virginia Commonwealth University School of Medicine. His legacy will live on through the works of countless researchers who continue working in the field of sphingolipids and many colleagues throughout the world will miss him tremendously.
In consideration of how we voice our opinions in the modern world, weve closed comments on our websites. We value the opinions of our readers and we encourage you to keep the conversation going.
Please feel free to share your story tips by emailing editor@mi-reporter.com.
To share your opinion for publication, submit a letter through our website https://www.mi-reporter.com/submit-letter/. Include your name, address and daytime phone number. (Well only publish your name and hometown.) We reserve the right to edit letters, but if you keep yours to 300 words or less, we wont ask you to shorten it.
Read this article:
'He was very honored in his work' - Mercer Island Reporter
- Secret to eternal youth? John Cleese extols virtues of stem cell treatment - The Guardian - April 26th, 2024
- Cabinet approves two bills on regenerative medicine - - April 26th, 2024
- Parental Fury After Stem Cell Bank Ruins Thousands of Samples in Singapore - Bloomberg - April 24th, 2024
- Pressure in the womb may influence facial development - Phys.org - April 24th, 2024
- Circadian regulation of cancer stem cells and the tumor microenvironment during metastasis - Nature.com - April 24th, 2024
- Shinobi strikes deal with electronics powerhouse Panasonic to create new cell therapy manufacturing platform - FiercePharma - April 19th, 2024
- The Stem Cells Market expected to grow at the value of USD 28.1 Billion by 2030 with a 10.48% CAGR. - WhaTech - April 19th, 2024
- Scientists produce in vitro model of cell differentiation during early facial development - Phys.org - April 19th, 2024
- Somite: AI-Based Stem Cell Therapy Company Closes $5.3 Million In Funding - Pulse 2.0 - April 19th, 2024
- Paralyzed man who can walk again shows potential benefit of stem cell therapy - ABC News - April 5th, 2024
- Stem Cells Market Innovations Investigated by Industry Overview and Global Forecast - WhaTech - April 5th, 2024
- New tool provides researchers with improved understanding of stem cell aging in the brain - University of Wisconsin-Madison - April 1st, 2024
- The PTM profiling of CTCF reveals the regulation of 3D chromatin structure by O-GlcNAcylation - Nature.com - April 1st, 2024
- Signatures of Autofluorescence Used To Study Stem Cells Aging in the Brain - Technology Networks - March 30th, 2024
- Two decades of embryonic stem cells: a historical overview - March 28th, 2024
- Researchers at Phoenix Children's First in the World to Produce Mouse Lungs in Rats - The Malaysian Reserve - March 26th, 2024
- Unlocking the mysteries of early human development through blastoid models - News-Medical.Net - March 24th, 2024
- Unlocking the Secrets of Aging: Researchers Reveal Key to Intestinal Balance - SciTechDaily - March 17th, 2024
- Human stem-cell-based therapy for Parkinson's disease proven safe PET - BioNews - March 13th, 2024
- Exploring the inner workings of stem cells: When location changes the message - Phys.org - March 9th, 2024
- Confronting IVF: Human Embryos Are Persons With a Right to Life - Walter Bradley Center for Natural and Artificial Intelligence - March 7th, 2024
- When Location Changes the Message - UConn Today - University of Connecticut - March 7th, 2024
- Distinct pathways drive anterior hypoblast specification in the implanting human embryo - Nature.com - March 6th, 2024
- In light of the Alabama court ruling, a look at the science of IVF : Short Wave - NPR - March 3rd, 2024
- The weird way Alabamas embryo ruling takes on artificial wombs - MIT Technology Review - February 25th, 2024
- Alabama's biggest hospital to suspend transfer of embryos after court ruling - ABC News - February 24th, 2024
- Stem Cells: FAQs Answered for Patients and Caregivers - Corporate Wellness Magazine - February 22nd, 2024
- Charles River Collaborates with Pluristyx, Expanding its Portfolio of Human Pluripotent Stem Cells - Business Wire - February 22nd, 2024
- Breakthrough Stem Cell Treatments for Stroke Recovery: What You Need to Know - Medical Tourism Magazine - February 20th, 2024
- Global Cell Isolation Market Size To Worth USD 13.4 Billion By 2033 | CAGR of 12.5% - Yahoo Finance - February 20th, 2024
- The Mechanism of Positional Cues in Embryonic Development and Signaling Molecules in Cell Fate - Medriva - February 18th, 2024
- Regeneration of the Retina Using Pluripotent Stem Cells: A Comprehensive Review - Cureus - February 5th, 2024
- CRISPR/Cas9-mediated deletion of a GA-repeat in human GPM6B leads to disruption of neural cell differentiation from ... - Nature.com - January 29th, 2024
- Global Human Embryonic Stem Cell Market Analysis 2024-2034: A Deep Dive into Applications, End-users, and ... - GlobeNewswire - January 26th, 2024
- No, Rep. Steve Scalise Didn't Vote Against Stem Cell Research From Which He Is Now Benefiting - Yahoo News - January 14th, 2024
- Clinical applications of stem cell-derived exosomes | Signal Transduction and Targeted Therapy - Nature.com - January 12th, 2024
- How Stem Cell Embryo Models Won Method of the Year - Technology Networks - January 12th, 2024
- Changing the public perception of human embryology - ESHRE - January 11th, 2024
- How the Human Body Regenerates New Cells Every Year - Laughing Squid - January 4th, 2024
- Lab-grown models of embryos increasingly resemble the real thing | Mint - Mint - January 4th, 2024
- Singapore should ban reproductive applications of synthetic human embryos - BioEdge - January 4th, 2024
- Machine learning-based estimation of spatial gene expression pattern during ESC-derived retinal organoid ... - Nature.com - December 21st, 2023
- The development of embryos may be less shaped by genes than we thought - New Scientist - December 21st, 2023
- Embryonic stem cell - Wikipedia - December 13th, 2023
- Researchers discover a mechanism that controls the identity of stem cells - Phys.org - December 9th, 2023
- 'Fascinating and completely unexpected': Tiny robots fix neurons - FierceBiotech - December 5th, 2023
- Establishment and characterization of matched immortalized human ... - Nature.com - December 5th, 2023
- Proteomic insights into the associations between obesity, lifestyle ... - BMC Medicine - December 5th, 2023
- New therapy can treat rare and hereditary diseases - ScienceNorway - December 5th, 2023
- Scientists Still Can't Be Trusted on Gene Editing - Progressive.org - December 5th, 2023
- Harvard Apparatus Regenerative Technology and Renowned ... - Yahoo Finance - December 5th, 2023
- 4.4 Million Funding Injection Fuels World-Class Bioscience Research Programme - India Education Diary - December 3rd, 2023
- A two-kinesin mechanism controls neurogenesis in the developing ... - Nature.com - December 3rd, 2023
- What happens when nature and cities collide - CNN - December 3rd, 2023
- Pro-Life This Week: December 1, 2023 | ALL - All.org - December 3rd, 2023
- A look at the international race to create human eggs and sperm in ... - NPR - December 1st, 2023
- Synthetic genetic circuits to uncover the OCT4 trajectories of ... - Science - December 1st, 2023
- Why the Novo Nordisk Foundation is betting big on stem cells - pharmaphorum - November 29th, 2023
- Charity Watchlist Helps Donors Ensure Their Year-End Gifts Don't ... - All.org - November 29th, 2023
- A green glowing monkey has been created in China. What were the ... - Genetic Literacy Project - November 29th, 2023
- Fetal Bovine Serum Market to reach USD 1.26 Bn by 2029, emerging at a CAGR of 5.3 percent according to a ne... - WhaTech Technology and Markets News - November 29th, 2023
- Implications of Gene Therapy in Dentistry and Periodontics: A ... - Cureus - November 27th, 2023
- Study shows how to treat hereditary, rare diseases - ETHealthWorld - November 27th, 2023
- Drugs identified that may reverse brain fog caused by COVID-19 - New Atlas - November 27th, 2023
- The genes that made us truly human may also make us ill - BBC.com - November 25th, 2023
- Therapy to treat rare, hereditary diseases: Study - Hindustan Times - November 25th, 2023
- How the growth of a giant single cell is intertwined with daily self-rhythms - Phys.org - November 25th, 2023
- On this day: Mahmoud Abbas becomes leader of Fatah in 2004 - In-Cyprus - November 25th, 2023
- Evaluation of A-ring hydroxymethylene-amino- triterpenoids as ... - Nature.com - November 25th, 2023
- Disruption of the autism gene and chromatin regulator KDM5A alters ... - Science - November 23rd, 2023
- Scientists Created a Monkey With Two Different Sets of DNA - Smithsonian Magazine - November 23rd, 2023
- Genomic tug of war could boost cancer therapy - Science Daily - November 23rd, 2023
- What are stem cells? Throw light on various types of stem cells and ... - Insights IAS - November 23rd, 2023
- The Paul G. Allen Family Foundation awards $10.5 million to new ... - EurekAlert - November 23rd, 2023
- Daily briefing: Why these PhD scientists went into teaching - Nature.com - November 23rd, 2023
- Innovative Therapy Targets Rare, Hereditary Diseases - Mirage News - November 23rd, 2023
- Scientists uncover "genomic tug of war" that influences ... - News-Medical.Net - November 21st, 2023
- DOT1L is a barrier to histone acetylation during reprogramming to ... - Science - November 21st, 2023
- Tumor microenvironment composition & related therapy in HCC | JHC - Dove Medical Press - November 21st, 2023
- T-Therapeutics raises $59M in series A for T-cell receptors - BioWorld Online - November 19th, 2023
Recent Comments